News
Suven Life Sciences reports consolidated net loss of Rs 45.60 crore in the March 2026 quarter
13-May-2026 | 15:13
Sales rise 3.40% to Rs 1.52 crore
Net Loss of Suven Life Sciences reported to Rs 45.60 crore in the quarter ended March 2026 as against net loss of Rs 43.94 crore during the previous quarter ended March 2025. Sales rose 3.40% to Rs 1.52 crore in the quarter ended March 2026 as against Rs 1.47 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 276.34 crore in the year ended March 2026 as against net loss of Rs 160.75 crore during the previous year ended March 2025. Sales rose 6.76% to Rs 7.11 crore in the year ended March 2026 as against Rs 6.66 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 1.52 | 1.47 | 3 | 7.11 | 6.66 | 7 |
| OPM % | -3331.58 | -2980.95 | - | -4001.41 | -2489.19 | - |
| PBDT | -44.01 | -42.60 | -3 | -270.73 | -154.92 | -75 |
| PBT | -45.60 | -43.94 | -4 | -276.34 | -160.75 | -72 |
| NP | -45.60 | -43.94 | -4 | -276.34 | -160.75 | -72 |
Powered by Capital Market - Live News
